1. You Are At:
  2. Home
  3. Business News
  4. Glenmark Pharma hits 52-week high after Forest Lab deal

Glenmark Pharma hits 52-week high after Forest Lab deal

New Delhi, Dec 24: Glenmark Pharmaceuticals rose by 4 per cent to hit its 52-week high of Rs 519.70 following the company's collaboration with Forest Laboratories for worldwide collaboration on Novel Agents to treat chronic

India TV Business Desk [ Updated: December 24, 2012 12:19 IST ]
glenmark pharma hits 52 week high after forest lab deal
glenmark pharma hits 52 week high after forest lab deal

New Delhi, Dec 24: Glenmark Pharmaceuticals rose by 4 per cent to hit its 52-week high of Rs 519.70 following the company's collaboration with Forest Laboratories for worldwide collaboration on Novel Agents to treat chronic inflammatory conditions.




"As per the agreement, Forest will make a $6 million upfront payment to Glenmark and provide an additional $3 million to support the next phase of work," said Glen Saldanha, Chairman and Managing Director at Glenmark Pharmaceuticals.

The BSE Sensex also rose 44.03 points, or 0.23%, to 19286.03.

Write a comment

Live Scorecard